Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment

from Rx for Biotech · host Podcast Host Chris Leidli

In this episode of Rx for Biotech, host Chris Leidli sits down with Dr. Frank Bedu-Addo, CEO of PDS Biotechnology, to discuss how the company is reimagining immunotherapy with its proprietary Versamune® T-cell activating platform.

Episode metadata supplied by the publisher feed · Published Aug 21, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment

0:00 39:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 39 minutes long.

When was this Rx for Biotech episode published?

This episode was published on August 21, 2025.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!